| Cost-effectiveness analyses of breast cancer medications use in developing countries: a systematic review NH Al-Ziftawi, AA Shafie, MI Mohamed Ibrahim Expert review of pharmacoeconomics & outcomes research 21 (4), 655-666, 2021 | 40 | 2021 |
| Assessment of knowledge, attitudes, and readiness to practice regarding disaster medicine and preparedness among university health students NH Al-Ziftawi, FM Elamin, MIM Ibrahim Disaster medicine and public health preparedness 15 (3), 316-324, 2021 | 27 | 2021 |
| Community pharmacists' participation in adult vaccination: A cross‐sectional survey based on the theoretical domains framework MS El Hajj, N Al‐Ziftawi, D Stewart, DMAY Al‐Khater British Journal of Clinical Pharmacology 89 (2), 773-786, 2023 | 10 | 2023 |
| Pill-burden and its association with treatment burden among patients with advanced stages of chronic kidney disease A Al-Mansouri, AI Hamad, FS Al-Ali, MIM Ibrahim, N Kheir, NH Al-Ziftawi, ... Saudi Pharmaceutical Journal 31 (5), 678-686, 2023 | 6 | 2023 |
| Cost-effectiveness and cost-utility of palbociclib versus ribociclib in women with stage IV breast cancer: A real-world data evaluation NH Al-Ziftawi, MF Alam, S Elazzazy, AA Shafie, A Hamad, ... International Journal of Environmental Research and Public Health 20 (1), 512, 2022 | 5 | 2022 |
| The Effectiveness and Safety of Palbociclib and Ribociclib in Stage IV HR+/HER-2 Negative Breast Cancer: A Nationwide Real World Comparative Retrospective Cohort Study NH Al-Ziftawi, S Elazzazy, MF Alam, AA Shafie, A Hamad, SB AL Bader, ... Frontiers in Oncology 13, 1203684, 2023 | 1 | 2023 |
| Efficacy and tolerability of sulforaphane in the therapeutic management of cancers: a systematic review of randomized controlled trials D ElKhalifa, N Al-Ziftawi, A Awaisu, F Alali, A Khalil Frontiers in Oncology 13, 1251895, 2023 | | 2023 |
| Abstract P3-16-03: Clinical and pharmacoeconomic analyses of CDK4/6 inhibitors use in stage IV breast cancer females in the state of Qatar: A comparative retrospective … NH Al-Ziftawi, S Elazzazy, MF Alam, AA Shafie, A Hamad, S Bujassoum, ... Cancer Research 82 (4_Supplement), P3-16-03-P3-16-03, 2022 | | 2022 |
| CLINICAL AND PHARMACOECONOMIC ANALYSES OF CDK4/6 INHIBITORS USE IN STAGE IV BREAST CANCER FEMALES IN THE STATE OF QATAR: A COMPARATIVE RETROSPECTIVE OBSERVATIONAL STUDY WITH … NH Al-Ziftawi | | 2021 |
